Essential role of the p38 mitogen-activated protein kinase pathway in tissue factor gene expression mediated by the phosphatidylserine-dependent antiprothrombin antibody

Rheumatology (United Kingdom)

Volumn 52, Issue 10, 2013, Pages 1775-1784

  Oku, Kenji ^a   Amengual, Olga ^a   Zigon, Polona ^b   Horita, Tetsuya ^a   Yasuda, Shinsuke ^a   Atsumi, Tatsuya ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Antiphospholipid syndrome; Antiprothrombin antibody; P38 MAPK; Procoagulant cell activation; Tissue factor

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; IMMUNOGLOBULIN G; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLSERINE; PROCOAGULANT; PROTHROMBIN ANTIBODY; THROMBOPLASTIN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BLOOD CLOTTING TIME; CELL SURFACE; ENZYME INHIBITION; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION;

EID: 84887324230     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket234     Document Type: Article

References (53)

1. Atsumi T, Amengual O, Koike T. Antiphospholipid syndrome: pathogenesis. In: Lahita R, ed. Systemic lupus erythematosus, 5th edn. San Diego, CA: Academic Press, 2010:945-66.
2. Hashimoto Y, Kawamura M, Ichikawa K et al. Anticardiolipin antibodies in NZW x BXSB F1 mice. A model of antiphospholipid syndrome. J Immunol 1992;149:1063-8.
3. Loeliger A. Prothrombin as a co-factor of the circulating anticoagulant in systemic lupus erythematosus? Thromb Diath Haemorrh 1959;3:237-56.
4. von Landenberg P, Matthias T, Zaech J et al. Antiprothrombin antibodies are associated with pregnancy loss in patients with the antiphospholipid syndrome. Am J Reprod Immunol 2003;49:51-6.
5. Zhao Y, Rumold R, Zhu M et al. An IgG antiprothrombin antibody enhances prothrombin binding to damaged endothelial cells and shortens plasma coagulation times. Arthritis Rheum 1999;42:2132-8.
6. Haj-Yahia S, Sherer Y, Blank M et al. Anti-prothrombin antibodies cause thrombosis in a novel qualitative ex-vivo animal model. Lupus 2003;12:364-9.
7. Galli M. Should we include anti-prothrombin antibodies in the screening for the antiphospholipid syndrome? J Autoimmun 2000;15:101-5.
8. Atsumi T, Ieko M, Bertolaccini ML et al. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthritis Rheum 2000;43:1982-93.
9. Oku K, Atsumi T, Amengual O et al. Antiprothrombin antibody testing: detection and clinical utility. Semin Thromb Hemost 2008;34:335-9.
10. Hoxha A, Ruffatti A, Tonello M et al. Antiphosphatidylserine/prothrombin antibodies in primary antiphospholipid syndrome. Lupus 2012;21:787-9.
11. Zigon P, Cucnik S, Ambrozic A et al. Antibodies to phosphatidylserine/prothrombin complex as an additional diagnostic marker of APS? Lupus 2012;21:790-2.
12. Otomo K, Atsumi T, Amengual O et al. Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events. Arthritis Rheum 2012;64:504-12.
13. Sakai Y, Atsumi T, Ieko M et al. The effects of phosphatidylserine-dependent antiprothrombin antibody on thrombin generation. Arthritis Rheum 2009;60:2457-67.
14. Atsumi T, Khamashta MA, Amengual O et al. Up-regulated tissue factor expression in antiphospholipid syndrome. Thromb Haemost 1997;77:222-3.
15. Amengual O, Atsumi T, Khamashta MA et al. The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome. Thromb Haemost 1998;79:276-81.
16. Xu G, Wen H, Zhou H et al. Involvement of IRAKs and TRAFs in anti-beta(2)GPI/beta(2)GPI-induced tissue factor expression in THP-1 cells. Thromb Haemost 2011;106:1158-69.
17. Meroni PL, Raschi E, Testoni C et al. Endothelial cell activation by antiphospholipid antibodies. Clin Immunol 2004;112:169-74.
18. Reverter JC, Tassies D, Font J et al. Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes. Arthritis Rheum 1998;41:1420-7.
19. Pierangeli SS, Colden-Stanfield M, Liu X et al. Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo. Circulation 1999;99:1997-2002.
20. Bohgaki M, Atsumi T, Yamashita Y et al. The p38 mitogenactivated protein kinase (MAPK) pathway mediates induction of the tissue factor gene in monocytes stimulated with human monoclonal anti-beta2Glycoprotein I antibodies. Int Immunol 2004;16:1633-41.
21. Vega-Ostertag M, Casper K, Swerlick R et al. Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies. Arthritis Rheum 2005;52:1545-54.
22. Lopez-Pedrera C, Buendia P, Cuadrado MJ et al. Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NFkappaB/Rel proteins via the p38 mitogen-activated protein kinase pathway, and of the MEK-1/ERK pathway. Arthritis Rheum 2006;54:301-11.
23. Zhou H, Wolberg AS, Roubey RA. Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazep. Blood 2004;104:2353-8.
24. Amengual O, Atsumi T, Koike T. Specificities, properties, and clinical significance of antiprothrombin antibodies. Arthritis Rheum 2003;48:886-95.
25. Ivison SM, Graham NR, Bernales CQ et al. Protein kinase D interaction with TLR5 is required for inflammatory signaling in response to bacterial flagellin. J Immunol 2007;178:5735-43.
26. Zhao X, Shi C, Wang X et al. Protein kinase C modulates the pulmonary inflammatory response in acute pancreatitis. Respir Physiol Neurobiol 2006;152:16-26.
27. Guma M, Hammaker D, Topolewski K et al. Pro-and antiinflammatory functions of the p38 pathway in rheumatoid arthritis: Advantages of targeting upstream kinases MKK3 or MKK6. Arthritis Rheum 2013 (in press).
28. Seo YJ, Pritzl CJ, Vijayan M et al. Sphingosine analogue AAL-R increases TLR7-mediated dendritic cell responses via p38 and type I IFN signaling pathways. J Immunol 2012;188:4759-68.
29. Mavropoulos A, Sully G, Cope AP et al. Stabilization of IFN-gamma mRNA by MAPK p38 in IL-12-and IL-18-stimulated human NK cells. Blood 2005;105:282-8.
30. O'Sullivan AW, Wang JH, Redmond HP. The role of P38 MAPK and PKC in BLP induced TNF-alpha release, apoptosis, and NFkappaB activation in THP-1 monocyte cells. J Surg Res 2009;151:138-44.
31. Noubade R, Krementsov DN, Del Rio R et al. Activation of p38 MAPK in CD4 T cells controls IL-17 production and autoimmune encephalomyelitis. Blood 2011;118:3290-300.
32. Moon C, Ahn M, Kim H et al. Activation of p38 mitogenactivated protein kinase in the early and peak phases of autoimmune neuritis in rat sciatic nerves. Brain Res 2005;1040:208-13.
33. Berkowitz P, Chua M, Liu Z et al. Autoantibodies in the autoimmune disease pemphigus foliaceus induce blistering via p38 mitogen-activated protein kinase-dependent signaling in the skin. Am J Pathol 2008;173:1628-36.
34. Schreiber S, Feagan B, D'Haens G et al. Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn's disease: a randomized, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol 2006;4:325-34.
35. Hajjar KA, Jacovina AT, Chacko J. An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J Biol Chem 1994;269:21191-7.
36. Kaczan-Bourgois D, Salles JP, Hullin F et al. Increased content of annexin II (p36) and p11 in human placenta brush-border membrane vesicles during syncytiotrophoblast maturation and differentiation. Placenta 1996;17:669-76.
37. Ma K, Simantov R, Zhang JC et al. High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin II. J Biol Chem 2000;275:15541-8.
38. Zhang J, McCrae KR. Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-beta2 glycoprotein I antibodies. Blood 2005;105:1964-9.
39. Zhou H, Ling S, Yu Y et al. Involvement of annexin A2 in anti-beta2GPI/beta2GPI-induced tissue factor expression on monocytes. Cell Res 2007;17:737-9.
40. Zhou H, Yan Y, Xu G et al. Toll-like receptor (TLR)-4 mediates anti-beta2GPI/beta2GPI-induced tissue factor expression in THP-1 cells. Clin Exp Immunol 2011;163:189-98.
41. Romay-Penabad Z, Montiel-Manzano MG, Shilagard T et al. Annexin A2 is involved in antiphospholipid antibodymediated pathogenic effects in vitro and in vivo. Blood 2009;114:3074-83.
42. Raschi E, Testoni C, Bosisio D et al. Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies. Blood 2003;101:3495-500.
43. Pierangeli SS, Vega-Ostertag ME, Raschi E et al. Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies. Ann Rheum Dis 2007;66:1327-33.
44. Satta N, Dunoyer-Geindre S, Reber G et al. The role of TLR2 in the inflammatory activation of mouse fibroblasts by human antiphospholipid antibodies. Blood 2007;109:1507-14.
45. Sorice M, Longo A, Capozzi A et al. Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts. Arthritis Rheum 2007;56:2687-97.
46. Pennings MT, van Lummel M, Derksen RH et al. Interaction of beta2-glycoprotein I with members of the low density lipoprotein receptor family. J Thromb Haemost 2006;4:1680-90.
47. Andersen OM, Benhayon D, Curran T et al. Differential binding of ligands to the apolipoprotein E receptor 2. Biochemistry 2003;42:9355-64.
48. Lutters BC, Derksen RH, Tekelenburg WL et al. Dimers of beta 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2'. J Biol Chem 2003;278:33831-8.
49. van Lummel M, Pennings MT, Derksen RH et al. The binding site in b2-glycoprotein I for ApoER2' on platelets is located in domain V. J Biol Chem 2005;280:36729-36.
50. Bohgaki M, Matsumoto M, Atsumi T et al. Plasma gelsolin facilitates interaction between beta2 glycoprotein I and alpha5beta1 integrin. J Cell Mol Med 2011;15:141-51.
51. Marai I, Carp H, Shai S et al. Autoantibody panel screening in recurrent miscarriages. Am J Reprod Immunol 2004;51:235-40.
52. Sugiura-Ogasawara M, Atsumi T, Ozaki Y et al. Phosphatidylserine-dependent antiprothrombin antibodies are not useful markers for high-risk women with recurrent miscarriages. Fertil Steril 2004;82:1440-2.
53. Yamada H, Atsumi T, Kobashi G et al. Antiphospholipid antibodies increase the risk of pregnancy-induced hypertension and adverse pregnancy outcomes. J Reprod Immunol 2009;79:188-95.